Perspective Therapeutics, Inc. (CATX)
USD 2.97
(-3.26%)
USD 2.97
(-3.26%)
| Breakdown | 2022 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.17 Million | -7.71 Million | -2.83 Million | -3.64 Million | -5.04 Million | -5.71 Million |
| Net Income | -14.67 Million | -7.27 Million | -3.38 Million | -3.44 Million | -5.14 Million | -6.7 Million |
| Depreciation & Amortization | 344 Thousand | 248 Thousand | 149 Thousand | 147 Thousand | 136 Thousand | 80 Thousand |
| Deferred income taxes | -1.68 Million | - | 10 Thousand | - | -24 Thousand | - |
| Stock-based compensation | 1.34 Million | 1.08 Million | 386 Thousand | 495 Thousand | 420 Thousand | 607 Thousand |
| Change in working capital | 338 Thousand | -1.85 Million | -67 Thousand | -835 Thousand | -518 Thousand | 222 Thousand |
| Other non-cash items | 472 Thousand | 77 Thousand | 72 Thousand | -2000.00 | 81 Thousand | 79 Thousand |
| Investing Cash Flow | -57.67 Million | -284 Thousand | -410 Thousand | -287 Thousand | 401 Thousand | 1.85 Million |
| Investments in PPE | -302 Thousand | -266 Thousand | -381 Thousand | -273 Thousand | -444 Thousand | -337 Thousand |
| Acquisitions | - | - | 1000.00 | - | 34 Thousand | - |
| Investment purchases | - | - | - | - | -4.72 Million | -4.05 Million |
| Sales/Maturities of investments | - | - | - | - | 5.55 Million | 6.26 Million |
| Other Investing Activities | -57.37 Million | -18 Thousand | -30 Thousand | -14 Thousand | -14 Thousand | -18 Thousand |
| Financing Cash Flow | 56 Thousand | 56 Thousand | 64.68 Million | 994 Thousand | 7.37 Million | 521 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -9000.00 | -11 Thousand | -11 Thousand | -11 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 56 Thousand | 64.69 Million | 1 Million | 7.38 Million | 532 Thousand |
| Other Financing Activities | 56 Thousand | - | - | - | - | - |
| Accounts receivables | 490 Thousand | 405 Thousand | 31 Thousand | -890 Thousand | 38 Thousand | -466 Thousand |
| Accounts payables | - | 236 Thousand | 76 Thousand | -29 Thousand | -708 Thousand | 761 Thousand |
| Inventory | -152 Thousand | -2.67 Million | -274 Thousand | -97 Thousand | 128 Thousand | 23 Thousand |
| Other working capital | - | 182 Thousand | 100 Thousand | 181 Thousand | 24 Thousand | -96 Thousand |
| Cash at beginning of period | 55.89 Million | 64.01 Million | 2.57 Million | 5.5 Million | 2.78 Million | 5.93 Million |
| Cash at end of period | 56.07 Million | 56.07 Million | 64.01 Million | 2.57 Million | 5.5 Million | 2.6 Million |
| Capital Expenditure | -302 Thousand | -266 Thousand | -381 Thousand | -273 Thousand | -444 Thousand | -337 Thousand |
| Effect of forex changes on cash | 61.85 Million | - | - | - | - | - |
| Net cash flow / Change in cash | 182 Thousand | -7.93 Million | 61.43 Million | -2.93 Million | 2.72 Million | -3.33 Million |
| Free Cash Flow | -12.47 Million | -7.97 Million | -3.21 Million | -3.91 Million | -5.49 Million | -6.04 Million |
| Breakdown | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 FY | 2022 Q1 | 2021 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.35 Million | -11.1 Million | -371 Thousand | -14.67 Million | -4.06 Million | -7.27 Million |
| Depreciation & Amortization | 259 Thousand | 245 Thousand | 180 Thousand | 344 Thousand | 68 Thousand | 248 Thousand |
| Deferred income taxes | 12 Thousand | 298 Thousand | -10.5 Million | -1.68 Million | - | - |
| Stock-based compensation | 451 Thousand | 1.19 Million | 1.36 Million | 1.34 Million | 465 Thousand | 1.08 Million |
| Change in working capital | -544 Thousand | 1.3 Million | -442 Thousand | 338 Thousand | 1.8 Million | -1.85 Million |
| Other non-cash items | 68 Thousand | -12 Thousand | 42 Thousand | 472 Thousand | -33 Thousand | 77 Thousand |
| Investing Cash Flow | -227 Thousand | -573 Thousand | 25.26 Million | -57.67 Million | -35.16 Million | -284 Thousand |
| Investments in PPE | -227 Thousand | -555 Thousand | -201 Thousand | -302 Thousand | -90 Thousand | -266 Thousand |
| Acquisitions | - | - | 2.69 Million | - | - | - |
| Investment purchases | - | - | -25.46 Million | - | -35.07 Million | - |
| Sales/Maturities of investments | - | - | 22.76 Million | - | - | - |
| Other Investing Activities | - | -18 Thousand | - | -57.37 Million | - | -18 Thousand |
| Financing Cash Flow | 1000.00 | 512 Thousand | -80 Thousand | 56 Thousand | 28 Thousand | 56 Thousand |
| Debt repayment | -21 Thousand | -20 Thousand | -15 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 22 Thousand | 532 Thousand | -65 Thousand | - | 28 Thousand | 56 Thousand |
| Other Financing Activities | - | - | - | 56 Thousand | - | - |
| Accounts receivables | -618 Thousand | 251 Thousand | -1000.00 | 490 Thousand | 395 Thousand | 405 Thousand |
| Accounts payables | -1.05 Million | 992 Thousand | -595 Thousand | - | 1.53 Million | 236 Thousand |
| Inventory | 113 Thousand | 16 Thousand | 128 Thousand | -152 Thousand | -95 Thousand | -2.67 Million |
| Other working capital | 1.01 Million | 45 Thousand | 26 Thousand | - | -25 Thousand | 182 Thousand |
| Cash at beginning of period | 28.5 Million | 36.63 Million | 21.17 Million | 55.89 Million | 56.07 Million | 64.01 Million |
| Cash at end of period | 18.16 Million | 28.5 Million | 36.63 Million | 56.07 Million | 19.17 Million | 56.07 Million |
| Capital Expenditure | -227 Thousand | -555 Thousand | -201 Thousand | -302 Thousand | -90 Thousand | -266 Thousand |
| Effect of forex changes on cash | - | - | - | 61.85 Million | - | - |
| Net cash flow / Change in cash | -10.33 Million | -8.13 Million | 15.45 Million | 182 Thousand | -36.9 Million | -7.93 Million |
| Free Cash Flow | -10.33 Million | -8.62 Million | -9.92 Million | -12.47 Million | -1.85 Million | -7.97 Million |
ONGC
KGPETRO
ELG
DDEJF
PRAJIND
3816